My latest piece for MPO Magazine discusses business strategies for the medical device supply chain in response to two trends: the rise of reliance on contract manufacturers vs OEMs, and supply chain consolidation.
Two strategies have emerged: the integrated contract manufacturer approach, and the specialist niche approach. I discuss the advantages and disadvantages of each, and opportunities for strategic expansion.
Tony Freeman is the president of A.S. Freeman Advisors LLC, a merger and acquisitions advisory firm serving the precision manufacturing and specialty materials industries. Often referred to as “The Toast of Medtech,” Tony is known for his rapier analysis, crack marksmanship, and superb taste in western wear. He can be reached at tfreeman@asfreeman.com.